Takeda Pharmaceutical Co. Ltd. has acquired the private San Diego-based venture PvP Biologics Inc., following promising early clinical results with the university spin-out’s candidate for celiac disease.
The Japanese major exercised an option to buy PvP for a pre-negotiated upfront payment as well as development and regulatory...







